Ribosome display and selection of human anti-CD22 scFvs derived from an acute lymphocytic leukemia patient

Biological Chemistry

Volumn 389, Issue 4, 2008, Pages 433-439

  Rothe, Achim ^a,b   Nathanielsz, Anne ^a   Oberhäuser, Frank ^b   Von Strandmann, Elke Pogge ^b   Engert, Andreas ^b   Hudson, Peter J ^a   Power, Barbara E ^a  

^a CSIRO   (Australia)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Antibody engineering; Immunotherapy; In vitro ribosome display

Indexed keywords

ANTIBODY; CD22 ANTIBODY; CD22 ANTIGEN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ACUTE LYMPHOCYTIC LEUKEMIA; ANTIBODY ENGINEERING; ANTIBODY ISOLATION; ANTIBODY LIBRARY; ANTIGEN BINDING; ARTICLE; CANCER PATIENT; CELL ASSAY; CELL STRAIN HEK293; CONJUGATION; CONTROLLED STUDY; DAUDI CELL; DISPLAY SYSTEM; EMBRYO; HUMAN; HUMAN CELL; IN VITRO STUDY; MAGNET; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROCESSING; RAJI CELL; RIBOSOME; SURFACE PLASMON RESONANCE; VALIDATION PROCESS;

ANTIBODIES; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIGENS, CD22; CELL LINE; HUMANS; IMMUNOGLOBULIN FRAGMENTS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RIBOSOMES; SURFACE PLASMON RESONANCE;

EUKARYOTA;

EID: 44649083142     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2008.045     Document Type: Article

References (19)

1. Binz, H.K., Amstütz, P., Kohl, A., Stumpp, M.T., Briand, C., Forrer, P., Grutter, M.G., and Plückthun, A. (2004). High-affinity binders selected from designed ankyrin repeat protein libraries. Nat. Biotechnol. 22, 575-582.
2. Boue, D.R. and LeBien, T.W. (1988). Expression and structure of CD22 in acute leukemia. Blood 71, 1480-1486.
3. Cesano, A. and Gayko, U. (2003). CD22 as a target of passive immunotherapy. Semin. Oncol. 30, 253-257.
4. Coia, G., Pontes-Braz, L., Nuttall, S.D., Hudson, P.J., and Irving, R.A. (2001). Panning and selection of proteins using ribosome display. J. Immunol. Methods 254, 191-197.
5. Ewert, S., Honegger, A., and Plückthun, A. (2004). Stability improvement of antibodies for extracellular and intracellular applications: CDR grafting to stable frameworks and structure-based framework engineering. Methods 34, 184-199.
6. Gokbuget, N. and Hoelzer, D. (2004). Treatment with monoclonal antibodies in acute lymphoblastic leukemia: current knowledge and future prospects. Ann. Hematol. 83, 201-205.
7. Hanes, J., Jermutus, L., Schaffitzel, C., and Plückthun, A. (1999). Comparison of Escherichia coli and rabbit reticulocyte ribosome display systems. FEBS Lett. 450, 105-110.
8. He, M. and Taussig, M.J. (2005). Ribosome display of antibodies: expression, specificity and recovery in a eukaryotic system. J. Immunol. Methods 297, 73-82.
9. He, M. and Taussig, M.J. (2007). Eukaryotic ribosome display with in situ DNA recovery. Nat. Methods 4, 281-288.
10. Herrera, L., Yarbrough, S., Ghetie, V., Aquino, D.B., and Vitetta, E.S. (2003). Treatment of SCID/human B cell precursor ALL with anti-CD19 and anti-CD22 immunotoxins. Leukemia 17, 334-338.
11. Holliger, P. and Hudson, P.J. (2005). Engineered antibody fragments and the rise of single domains. Nat. Biotechnol. 23, 1126-1136.
12. Juraja, S.M., Mulhern, T.D., Hudson, P.J., Hattarki, M.K., Carmichael, J.A., and Nuttall, S.D. (2006). Engineering of the Escherichia coli Im7 immunity protein as a loop display scaffold. Protein Eng. Des. Sel. 19, 231-244.
13. Leemhuis, H., Stein, V., Griffiths, A.D., and Hollfelder, F. (2005). New genotype-phenotype linkages for directed evolution of functional proteins. Curr. Opin. Struct. Biol. 15, 472-478.
14. Leonard, J.P., Coleman, M., Ketas, J.C., Chadburn, A., Furman, R., Schuster, M.W., Feldman, E.J., Ashe, M., Schuster, S.J., Wegener, W.A., et al. (2004). Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results. Clin. Cancer Res. 10, 5327-5334.
15. Mustafa, H., Strasser, B., Rauth, S., Irving, R.A., and Wark, K.L. (2006). Identification of a functional nuclear export signal in the green fluorescent protein asFP499. Biochem. Biophys. Res. Commun. 342, 1178-1182.
16. Rothe, A., Klimka, A., Tur, M.K., Pfitzner, T., Huhn, M., Sasse, S., Mallmann, P., Engert, A., and Barth, S. (2004). Construction of phage display libraries from reactive lymph nodes of breast carcinoma patients and selection for specifically binding human single chain Fv on cell lines. Int. J. Mol. Med. 14, 729-735.
17. Rothe, A., Hosse, R.J., and Power, B.E. (2006). Ribosome display for improved biotherapeutic molecules. Expert Opin. Biol. Ther. 6, 177-187.
18. Wu, C.J., Yang, X.F., McLaughlin, S., Neuberg, D., Canning, C., Stein, B., Alyea, E.P., Soiffer, R.J., Dranoff, G., and Ritz, J. (2000). Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia. J. Clin. Invest. 106, 705-714.
19. Zahnd, C., Amstütz, P., and Plückthun, A. (2007). Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target. Nat. Methods 4, 269-279.